Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

5-Alpha-Reductase Inhibitors can cause negative side effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.